14-20584057-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_145250.5(RNASE11):​c.418G>T​(p.Val140Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000296 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

RNASE11
NM_145250.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.51
Variant links:
Genes affected
RNASE11 (HGNC:19269): (ribonuclease A family member 11 (inactive)) Predicted to enable endonuclease activity and nucleic acid binding activity. Predicted to be involved in nucleic acid phosphodiester bond hydrolysis. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.042310238).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNASE11NM_001394189.1 linkc.418G>T p.Val140Leu missense_variant Exon 3 of 3 NP_001381118.1
RNASE11NM_001394190.1 linkc.418G>T p.Val140Leu missense_variant Exon 3 of 3 NP_001381119.1
RNASE11NM_001394191.1 linkc.418G>T p.Val140Leu missense_variant Exon 3 of 3 NP_001381120.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNASE11ENST00000557105.6 linkc.418G>T p.Val140Leu missense_variant Exon 3 of 3 3 ENSP00000452412.2 G3V5L6

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
34
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000179
AC:
45
AN:
251314
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000387
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000304
AC:
444
AN:
1461852
Hom.:
0
Cov.:
31
AF XY:
0.000259
AC XY:
188
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000388
Gnomad4 OTH exome
AF:
0.000182
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152238
Hom.:
0
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000470
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000268
Hom.:
0
Bravo
AF:
0.000196
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 08, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.418G>T (p.V140L) alteration is located in exon 3 (coding exon 1) of the RNASE11 gene. This alteration results from a G to T substitution at nucleotide position 418, causing the valine (V) at amino acid position 140 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
19
DANN
Benign
0.96
DEOGEN2
Benign
0.0056
T;T;T;T;T;T;.;.;.;.
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.76
FATHMM_MKL
Benign
0.068
N
LIST_S2
Benign
0.46
.;.;.;T;.;.;.;T;T;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.042
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.28
T
MutationAssessor
Benign
0.0
N;N;N;N;N;N;.;.;.;.
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.75
N;N;N;.;N;N;N;N;N;N
REVEL
Benign
0.046
Sift
Benign
0.17
T;T;T;.;T;T;T;T;T;T
Sift4G
Benign
0.26
T;T;T;T;T;T;.;.;.;.
Polyphen
0.069
B;B;B;B;B;B;.;.;.;.
Vest4
0.091
MutPred
0.28
Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);Gain of catalytic residue at Q141 (P = 4e-04);
MVP
0.39
ClinPred
0.053
T
GERP RS
3.0
Varity_R
0.078
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375334814; hg19: chr14-21052216; API